oxazoles has been researched along with Lung Diseases, Obstructive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bründler, H; Godly, R; Herzog, H; Imhof, E; Perruchoud, AP | 1 |
Cafaggi, R; D'Onofrio, V; Giosuè, S; Guerrini, P; Perrone, N; Scano, M | 1 |
Casali, L; Colombo, ML; Manazza, P; Rossi, A; Zoia, MC | 1 |
2 trial(s) available for oxazoles and Lung Diseases, Obstructive
Article | Year |
---|---|
Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Double-Blind Method; Female; Hemodynamics; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Random Allocation; Respiratory Function Tests | 1987 |
A comparison of the bronchodilator effects of broxaterol and salbutamol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Blood Pressure; Bronchodilator Agents; Female; Heart Rate; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Respiratory Function Tests; Time Factors | 1988 |
1 other study(ies) available for oxazoles and Lung Diseases, Obstructive
Article | Year |
---|---|
[Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Female; Forced Expiratory Volume; Humans; Isoxazoles; Lung Diseases, Obstructive; Male; Middle Aged; Oxazoles; Vital Capacity | 1987 |